Clinical Experts Issue Special Report Calling for Greater Education, Testing, and Prevention of In Vitro Hemolysis in High-Risk Settings
Montreal-based contract research organisation Indero has completed an internally funded study demonstrating that quantitative gene expression analysis can assess topical new chemical entities in early-phase clinical research within three days, substantially reducing the time and cost associated with traditional evaluation methods.
Johnson & Johnson has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc. for US$3.05 billion in cash, securing access to a clinical-stage prostate cancer therapy and a proprietary platform technology designed to develop oral targeted treatments for solid tumours. The transaction is expected to close within the coming months pending antitrust clearance […]
St. Jude Children’s Research Hospital scientists have launched AlphaSync, a free database addressing a critical gap in structural biology by continuously synchronising predicted protein structures with the latest sequence data from UniProt. The resource currently provides 2.6 million updated structural models across 925 species, including disease-relevant proteins previously missing from existing databases.
A Finnish biotechnology company has opened applications for a global scientific competition designed to advance understanding of cellular redox metabolism, offering successful applicants access to precision measurement technology and expert support valued at up to $30,000.
MOLCURE Inc. has announced a multiyear strategic research agreement with Boehringer Ingelheim to discover innovative antibody therapeutics for multiple targets using the Japanese company’s proprietary artificial intelligence platform technology. The collaboration will combine MOLCURE’s AI-driven platform with Boehringer Ingelheim’s expertise in biologics development, aiming to expand the scope and efficiency of antibody drug discovery beyond […]
French biopharmaceutical company StemInov has closed a €10.6 million financing round to support the industrialisation of its stem cell platform and prepare for Phase I/IIa clinical trials targeting severe pneumonia complications. The Nancy and Illkirch-Graffenstaden-based company, which specialises in mesenchymal stem cell (MSC) therapies for inflammatory and autoimmune diseases, expects to initiate patient recruitment in […]
Cambridge-based Owlstone Medical has been awarded up to US$49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a multi-cancer early detection test that can be performed at home using breath and urine samples. The funding forms part of ARPA-H’s Platform Optimising SynBio for Early Intervention and Detection in Oncology (POSEIDON) programme, […]
French pharmaceutical company Theranexus has announced its transformation into THX Pharma, marking a strategic pivot from biotechnology research towards regulatory approval and commercial deployment of treatments for rare neurological diseases. The rebranding of the Lyon-based company positions it to advance two lead drug candidates through registration and international market access.
Neogap Therapeutics AB has been granted Chinese patent protecting its proprietary method for expanding tumour-specific T cells, marking a significant milestone in the company’s international intellectual property strategy. The patent, which provides legal protection until 2038, covers a core manufacturing process for the company’s personalised cell-based immunotherapy, pTTL, currently under evaluation in Phase I/II clinical […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
